Thus, serum FGF23 levels increase in early-stage CKD (before serum phosphate levels becomes abnormal) [92,95], maintains a neutral phosphate balance, has a reduced renal calcitriol production, and thereby stimulates PTH secretion [96]. This evidence concerns the gene FGF23 and chronic kidney disease.